COVID-19: FDA Expands Overseas Inspections Freeze Through April

Industry experts advise companies to prepare for paper-based inspection in light of the US FDA's suspended overseas inspections in response to the COVID-19 crisis.

MT2002_Coronavirus Map_1627847941_1200.jpg

More from Regulation

More from Policy & Regulation